Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.
暂无分享,去创建一个
Michael Gill | Hans-Jürgen Möller | Pierandrea Muglia | Michael J Owen | Nadine Norton | Aiden Corvin | Gary Donohoe | D. Rujescu | P. Muglia | I. Giegling | H. Möller | A. Hartmann | M. Gill | M. Owen | V. Moskvina | A. Corvin | D. Morris | N. Norton | H. Williams | G. Donohoe | E. Quinn | J. Walters | M. O’Donovan | T. O’Donoghue | Hywel Williams | Annette M Hartmann | Ina Giegling | Derek W Morris | Dan Rujescu | Valentina Moskvina | Michael C O'Donovan | Emma M Quinn | Róisín Judge | Therese O'Donoghue | James Walters | Rosemary Peel | Róisín Judge | Rosemary Peel | J. Walters
[1] J. Stockman. Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes , 2010 .
[2] Christian von Mering,et al. STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..
[3] Ann-Christine Ehlis,et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. , 2009, Archives of general psychiatry.
[4] Lin He,et al. Evidence for association between the 5' flank of the NOS1 gene and schizophrenia in the Chinese population. , 2008, The international journal of neuropsychopharmacology.
[5] P. Visscher,et al. Rare chromosomal deletions and duplications increase risk of schizophrenia , 2008, Nature.
[6] Thomas W. Mühleisen,et al. Large recurrent microdeletions associated with schizophrenia , 2008, Nature.
[7] C. Spencer,et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up , 2008, Nature Genetics.
[8] Marcus R. Munafò,et al. Meta-Analysis of the Cognitive Effects of the Catechol-O-Methyltransferase Gene Val158/108Met Polymorphism , 2008, Biological Psychiatry.
[9] G. Feng,et al. Family-based association studies of CAPON and schizophrenia in the Chinese Han population , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[10] A. Fanous,et al. Genetics of clinical features and subtypes of schizophrenia: A review of the recent literature , 2008, Current psychiatry reports.
[11] A. Singleton,et al. Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.
[12] P. Sullivan. Schizophrenia genetics: the search for a hard lead , 2008, Current opinion in psychiatry.
[13] M. Gill,et al. A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis , 2008, Neuroscience Letters.
[14] R. Feil,et al. NO/cGMP-dependent modulation of synaptic transmission. , 2008, Handbook of experimental pharmacology.
[15] M. Gill,et al. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: A preliminary study , 2007, Neuropsychologia.
[16] Todd Lencz,et al. Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia , 2007, Proceedings of the National Academy of Sciences.
[17] M. Moreau,et al. Association of synapsin 2 with schizophrenia in families of Northern European ancestry , 2007, Schizophrenia Research.
[18] Andreas Buchmann,et al. Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance. , 2007, Human molecular genetics.
[19] H. Herken,et al. Increased Levels of Nitric Oxide, Cortisol and Adrenomedullin in Patients with Chronic Schizophrenia , 2007, Medical Principles and Practice.
[20] 山田 立子,et al. No genetic association between postsynaptic density-95 gene polymorphisms and schizophrenia , 2007 .
[21] Kim Fejgin,et al. The amino acid l-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice , 2007, Psychopharmacology.
[22] T. Archer,et al. Phencyclidine affects memory in a nitric oxide-dependent manner: Working and reference memory , 2006, Behavioural Brain Research.
[23] Sarah A. J. Reading,et al. Neurobiology of Schizophrenia , 2006, Neuron.
[24] A. Meyer-Lindenberg,et al. Intermediate phenotypes and genetic mechanisms of psychiatric disorders , 2006, Nature Reviews Neuroscience.
[25] Trevor Archer,et al. Effects of phencyclidine on spatial learning and memory: Nitric oxide-dependent mechanisms , 2006, Behavioural Brain Research.
[26] M. Gill,et al. Are deficits in executive sub-processes simply reflecting more general cognitive decline in schizophrenia? , 2006, Schizophrenia Research.
[27] Birgit Funke,et al. Genetic variation in DTNBP1 influences general cognitive ability. , 2006, Human molecular genetics.
[28] B. Sahakian,et al. Cognitive reserve in neuropsychiatry , 2006, Psychological Medicine.
[29] U. Förstermann,et al. Transcription of human neuronal nitric oxide synthase mRNAs derived from different first exons is partly controlled by exon 1-specific promoter sequences. , 2006, Genomics.
[30] Andreas Papassotiropoulos,et al. Identification of a genetic cluster influencing memory performance and hippocampal activity in humans. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[31] D Saur,et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function , 2006, Molecular Psychiatry.
[32] H. Gurling,et al. Failure to Confirm Allelic Association Between Markers at the CAPON Gene Locus and Schizophrenia in a British Sample , 2006, Biological Psychiatry.
[33] S. Tsai,et al. Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia , 2006, Journal of Neural Transmission.
[34] R. Huganir,et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. , 2005, American journal of human genetics.
[35] Philip D. Harvey,et al. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. , 2005, Archives of general psychiatry.
[36] Jörgen A. Engel,et al. Effects of phencyclidine on acoustic startle and prepulse inhibition in neuronal nitric oxide synthase deficient mice , 2005, European Neuropsychopharmacology.
[37] C. Ommen. Putting the PC in IQ: Images in the Weschler Adult Intelligence Scale – Third Edition (WAIS III) , 2005 .
[38] Hiroki Shibata,et al. Association study of polymorphisms in synaptic vesicle-associated genes, SYN2 and CPLX2, with schizophrenia , 2005, Behavioral and Brain Functions.
[39] Shi-yu Guo,et al. The role of norepinephrine and nitric oxide in activities of rat arginine vasopressin neurons in response to immune challenge , 2005, Neuroscience Letters.
[40] Lin He,et al. Association of the carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase gene with schizophrenia in the Chinese Han population. , 2005, Biochemical and biophysical research communications.
[41] Paul J. Harrison,et al. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.
[42] Mario Engelmann,et al. Impaired cognitive performance in neuronal nitric oxide synthase knockout mice is associated with hippocampal protein derangements. , 2004, Nitric oxide : biology and chemistry.
[43] J. Engel,et al. The neuronal selective nitric oxide synthase inhibitor, Nomega-propyl-L-arginine, blocks the effects of phencyclidine on prepulse inhibition and locomotor activity in mice. , 2004, European journal of pharmacology.
[44] B. Uyanık,et al. Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia. , 2004, Archives of medical research.
[45] Jörgen A. Engel,et al. Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms , 2004, Psychopharmacology.
[46] Mario Engelmann,et al. Neuronal nitric oxide synthase knock-out mice show impaired cognitive performance. , 2004, Nitric oxide : biology and chemistry.
[47] A. Bassett,et al. Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. , 2004, American journal of human genetics.
[48] P. Emson,et al. Expression of nNOS and soluble guanylate cyclase in schizophrenic brain , 2004, Neuroreport.
[49] J. Engel,et al. Phencyclidine-induced behaviour in mice prevented by methylene blue. , 2004, Basic & clinical pharmacology & toxicology.
[50] 馬場 元. Expression of nNOS and soluble guanylate cyclase in schizophrenic brain , 2004 .
[51] Adam J. Smith,et al. The Database of Interacting Proteins: 2004 update , 2004, Nucleic Acids Res..
[52] Martin Vingron,et al. IntAct: an open source molecular interaction database , 2004, Nucleic Acids Res..
[53] Shih-Jen Tsai,et al. Association analysis for the CA repeat polymorphism of the neuronal nitric oxide synthase (NOS1) gene and schizophrenia , 2003, Schizophrenia Research.
[54] M. Skolnick,et al. Predisposition locus for major depression at chromosome 12q22-12q23.2. , 2003, American journal of human genetics.
[55] I. Gottesman,et al. The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.
[56] U. Förstermann,et al. Transcription of Different Exons 1 of the Human Neuronal Nitric Oxide Synthase Gene Is Dynamically Regulated in a Cell- and Stimulus- Specific Manner , 2003, Biological chemistry.
[57] R. Plomin. Genetics, genes, genomics and g , 2003, Molecular Psychiatry.
[58] Asaf Caspi,et al. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. , 2002, The American journal of psychiatry.
[59] Dimitris Fouskakis,et al. Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia , 2002, British Journal of Psychiatry.
[60] K. Hornik,et al. Genome scan for susceptibility loci for schizophrenia and bipolar disorder , 2002, Biological Psychiatry.
[61] Richie Poulton,et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. , 2002, Archives of general psychiatry.
[62] John Stewart,et al. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. , 2002, The American journal of psychiatry.
[63] Robert Plomin,et al. Genetics and general cognitive ability (g) , 2002, Trends in Cognitive Sciences.
[64] T. Shinkai,et al. Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia , 2002, Molecular Psychiatry.
[65] R. Straub,et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[66] Ioannis Xenarios,et al. DIP: The Database of Interacting Proteins: 2001 update , 2001, Nucleic Acids Res..
[67] Gary D Bader,et al. BIND--The Biomolecular Interaction Network Database. , 2001, Nucleic acids research.
[68] K. Hornik,et al. Genome Scan for Susceptibility Loci for Schizophrenia , 2000, Neuropsychobiology.
[69] I. Gottesman,et al. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. , 2000, American journal of medical genetics.
[70] A Reichenberg,et al. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. , 1999, The American journal of psychiatry.
[71] Randall W Engle,et al. Working memory, short-term memory, and general fluid intelligence: a latent-variable approach. , 1999, Journal of experimental psychology. General.
[72] Jörgen A. Engel,et al. The nitric oxide synthase inhibitor. L-NAME, blocks certain phencyclidine-induced but not amphetamine-induced effects on behaviour and brain biochemistry in the rat , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[73] M. Tsuang,et al. IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study. , 1998, The American journal of psychiatry.
[74] R. Heinrichs,et al. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. , 1998, Neuropsychology.
[75] A. David,et al. IQ and risk for schizophrenia: a population-based cohort study , 1997, Psychological Medicine.
[76] D. Jackson,et al. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat , 1997, Psychopharmacology.
[77] M. First,et al. Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .
[78] Thomas R. Carretta,et al. Cognitive-Components Tests Are Not Much More Than g: An Extension of Kyllonen's Analyses , 1996 .
[79] J. Rice,et al. Comparison of direct interview and family history diagnoses of alcohol dependence. , 1995, Alcoholism, clinical and experimental research.
[80] S. Hirsch,et al. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. , 1995, Biochemical and biophysical research communications.
[81] T. Crow,et al. Childhood precursors of psychosis as clues to its evolutionary origins. , 1995, European archives of psychiatry and clinical neuroscience.
[82] P. Marsden,et al. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). , 1994, The Journal of biological chemistry.
[83] J J Kim,et al. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. , 1993, Archives of general psychiatry.
[84] C A Sandman,et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. , 1993, Archives of general psychiatry.
[85] Robert A. Bornstein,et al. The Wechsler Memory Scale—Revised , 1990 .
[86] N. Mimica,et al. Scale for the Assessment of Negative Symptoms (SANS)* , 1989, British Journal of Psychiatry.
[87] N. Risch,et al. The continuous performance test, identical pairs version (CPT-IP): I. new findings about sustained attention in normal families , 1988, Psychiatry Research.
[88] C. Reynolds,et al. Wechsler memory scale-revised , 1988 .
[89] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.